National HealthCare Past Earnings Performance
Past criteria checks 3/6
National HealthCare's earnings have been declining at an average annual rate of -5%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 2.8% per year. National HealthCare's return on equity is 7.2%, and it has net margins of 5.9%.
Key information
-5.0%
Earnings growth rate
-5.1%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 2.8% |
| Return on equity | 7.2% |
| Net Margin | 5.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All
May 01
Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture
Apr 09Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?
Mar 17National HealthCare Corporation's (NYSEMKT:NHC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?
Mar 02National HealthCare Corporation (NYSEMKT:NHC) Insiders Have Been Selling
Feb 15
Reflecting on National HealthCare's (NYSEMKT:NHC) Share Price Returns Over The Last Year
Feb 02Could The National HealthCare Corporation (NYSEMKT:NHC) Ownership Structure Tell Us Something Useful?
Jan 20These Metrics Don't Make National HealthCare (NYSEMKT:NHC) Look Too Strong
Jan 07Do These 3 Checks Before Buying National HealthCare Corporation (NYSEMKT:NHC) For Its Upcoming Dividend
Dec 25What We Learned About National HealthCare's (NYSEMKT:NHC) CEO Pay
Dec 24Is National HealthCare Corporation's (NYSEMKT:NHC) 3.1% Dividend Worth Your Time?
Dec 12Does National HealthCare Corporation's (NYSEMKT:NHC) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?
Nov 30Revenue & Expenses BreakdownBeta
How National HealthCare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,135 | 67 | 42 | 0 |
| 30 Sep 23 | 1,105 | 45 | 40 | 0 |
| 30 Jun 23 | 1,087 | 32 | 40 | 0 |
| 31 Mar 23 | 1,075 | 19 | 41 | 0 |
| 31 Dec 22 | 1,074 | 22 | 41 | 0 |
| 30 Sep 22 | 1,079 | 32 | 41 | 0 |
| 30 Jun 22 | 1,074 | 31 | 41 | 0 |
| 31 Mar 22 | 1,051 | 133 | 41 | 0 |
| 31 Dec 21 | 1,011 | 139 | 41 | 0 |
| 30 Sep 21 | 989 | 150 | 40 | 0 |
| 30 Jun 21 | 961 | 167 | 40 | 0 |
| 31 Mar 21 | 950 | 90 | 40 | 0 |
| 31 Dec 20 | 978 | 42 | 40 | 0 |
| 30 Sep 20 | 985 | 28 | 41 | 0 |
| 30 Jun 20 | 994 | 35 | 41 | 0 |
| 31 Mar 20 | 1,004 | 20 | 41 | 0 |
| 31 Dec 19 | 996 | 68 | 41 | 0 |
| 30 Sep 19 | 990 | 73 | 41 | 0 |
| 30 Jun 19 | 989 | 74 | 41 | 0 |
| 31 Mar 19 | 984 | 83 | 41 | 0 |
| 31 Dec 18 | 979 | 59 | 41 | 0 |
| 30 Sep 18 | 977 | 62 | 41 | 0 |
| 30 Jun 18 | 972 | 52 | 41 | 0 |
| 31 Mar 18 | 968 | 41 | 41 | 0 |
| 31 Dec 17 | 964 | 56 | 40 | 0 |
| 30 Sep 17 | 956 | 49 | 41 | 0 |
| 30 Jun 17 | 947 | 48 | 41 | 0 |
| 31 Mar 17 | 936 | 50 | 41 | 0 |
| 31 Dec 16 | 924 | 51 | 41 | 0 |
| 30 Sep 16 | 923 | 51 | 41 | 0 |
| 30 Jun 16 | 917 | 51 | 41 | 0 |
| 31 Mar 16 | 914 | 49 | 40 | 0 |
| 31 Dec 15 | 907 | 46 | 40 | 0 |
| 30 Sep 15 | 899 | 44 | 40 | 0 |
| 30 Jun 15 | 892 | 45 | 40 | 0 |
| 31 Mar 15 | 884 | 45 | 40 | 0 |
| 31 Dec 14 | 872 | 45 | 40 | 0 |
| 30 Sep 14 | 852 | 46 | 40 | 0 |
| 30 Jun 14 | 830 | 54 | 40 | 0 |
| 31 Mar 14 | 805 | 55 | 39 | 0 |
| 31 Dec 13 | 789 | 56 | 39 | 0 |
| 30 Sep 13 | 773 | 55 | 39 | 0 |
| 30 Jun 13 | 767 | 53 | 39 | 0 |
Quality Earnings: NHC has a large one-off gain of $20.5M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: NHC's current net profit margins (5.9%) are higher than last year (2.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NHC's earnings have declined by 5% per year over the past 5 years.
Accelerating Growth: NHC's earnings growth over the past year (197.6%) exceeds its 5-year average (-5% per year).
Earnings vs Industry: NHC earnings growth over the past year (197.6%) exceeded the Healthcare industry 7.1%.
Return on Equity
High ROE: NHC's Return on Equity (7.2%) is considered low.